# Biomarkers for Differentiating Reversible and Irreversible Pulpitis

> **NCT07658742** · — · COMPLETED · sponsor: **Safa** · enrollment: 90 (actual)

## Conditions studied

- Reversible Pulpitis
- Irreversible Pulpitis
- Healthy Pulp

## Interventions

- **DIAGNOSTIC_TEST:** Pulpal Blood Biomarker Analysis

## Key facts

- **NCT ID:** NCT07658742
- **Lead sponsor:** Safa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-10
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658742, "Biomarkers for Differentiating Reversible and Irreversible Pulpitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07658742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*